Machine Learning May Help Classify Cancers of Unknown Primary https://bit.ly/37dB2VV
TWILIGHT showed short-duration #DAPT followed by ticagrelor monotherapy for 12 months results in less bleeding vs. longer-duration DAPT among patients undergoing #PCI w/ a DES & at high ischemic or bleeding risk. Read more: https://bit.ly/2CRzyT9 #AHA19
It was worth the wait! 10/10 selfie!
Finally happened: got a #SurgSelfie with @aribindi at @AmerMedicalAssn #AMAmtg
Thank you for joining us the 2019 Interim #AMAmtg!
@aafp delegation at @AmerMedicalAssn #AMAmtg #FamilyMedicineStrong
"#Medicare should establish policies to ensure that #ACOs and MA plans are treated fairly, but such policies must account for the substantial differences in the way those alternatives operate."
http://bit.ly/32MzoXE
#earlybird registration ends in 8 days. Register now to get the special early bird rate for #TEDMED 2020. http://ow.ly/BLCr50xc4cJ #makewayforwonder
The best outcomes will likely require powerful technologies optimally mixed with distinctively human capabilities -- a partnership that will shape the future of medicine, says @CEO_AMA in his opening address at #AMAmtg. Watch now. http://spr.ly/60131373f
Dr. Peter Block interviewed presenter Dr. Felipe Martinez regarding the effect of treatment according to age in the DAPA-HF trial. Watch the video: https://bit.ly/2q9YXot #AHA19
Watch the Presidential Session happening now with some of the biggest moments of #AHA19. YouTube will livestream the entire session. Twitter will stream speeches by AHA leaders. Use these links: YouTube: http://spr.ly/6013137Rx or Twitter: http://spr.ly/6014137RI.
Women had fewer OHCA’s in public locations that lacked public access defibrillators (PAD) and were less likely to have PAD used by bystanders in public locations. http://spr.ly/601213W4K #ReSS19 @BrianGrunau @CHEOSNews @BCEmergMedNtwrk
What do @Beyonce, Stephen Covey and Mr. Rogers have in common with each other, let alone with physicians? Watch @PatriceHarrisMD's #AMAmtg opening address to find out. http://spr.ly/6014137JG
#PARAGONHF / #PARADIGMHF: Across the spectrum of EF in HF, primary composite event rates decreased as LVEF increased. http://spr.ly/6017137yB #AHA19 @scottdsolomon @BrighamWomens
Female leaders of cardiovascular societies gather at #AHA19, including our very own ACC Vice President Dr. Athena Poppas! #ACCWIC
#PARAGONHF: Effects of sacubitril/valsartan, compared to valsartan, in women versus men with HFpEF suggested less risk of HF hospitalization in women. Findings need further study. http://spr.ly/6010137Ba #AHA19 @EdinUniCVS #cardiotwitter
#DAPAHF: HF-QOL and symptoms improved for HFrEF patients with dapagliflozin compared to placebo. http://spr.ly/601713AN5 #AHA19 @EdinUniCVS #cardiotwitter
"WHO is proud to be working with @_AfricanUnion countries… The signing of a new Memorandum of Understanding between our two organizations will help us to formalize our cooperation in three key areas"-@DrTedros
Stop Blaming The Victim: The Case For Systemic #HealthSystem Transparency by @N_Brennan
+ Katie Martin.
http://bit.ly/2rvOaoG
Stay in the know with the latest news coming out of the 2019 Interim #AMAmtg! http://spr.ly/6014132B8
When Candace needed cancer treatment that was far from her house, she found a home away from home with the @ExtendedStay America Hotel Keys of Hope program. #StayStory https://www.cancer.org/our-partners/extended-stay-america.html
Find out what's in the new proposed rule on health insurer transparency. And watch Health Affairs Blog for a coming analysis of the new hospital transparency rule. #Keithitcoming https://www.healthaffairs.org/do/10.1377/hblog20191117.364191/full/
#DAPAHF: Dapagliflozin + standard therapy lowered the risk of worsening HF events, CV death, and improved symptoms across age groups for patients with HFrEF. http://spr.ly/601413AWC #AHA19 #cardiotwitter
DAPA-HF showed that dapagliflozin was superior to placebo at preventing cardiovascular deaths & #HeartFailure events. Read more: https://bit.ly/32TBhBS #AHA19
#FUEL: Exercise performance measures improved with udenafil treatment after Fontan. More study needed. http://spr.ly/601713Acz #AHA19 @ChildrensPhila
Impella® use associated with variability in use and outcomes and higher adverse events and costs. http://spr.ly/601613Awr #AHA19 @WUSTLmed
FUEL showed that udenafil is not superior to placebo at improving oxygen consumption at peak exercise among compensated patients with Fontan physiology. Read more: https://bit.ly/2KJR3t5 #AHA19
#COACT: CV outcomes not better at 1 year for immediate coronary angiography after non-STEMI compared to a delayed strategy. http://spr.ly/601413Au4 #AHA19 #cardiotwitter
Today is #WorldDayofRemembrance for traffic victims. Road traffic crashes kill more than 1.35 million people each year. Learn road safety tips for home and abroad: https://go.usa.gov/xpYvR.
RENAL-AF showed that apixaban 5 mg BID results in similar rates of bleeding & strokes as warfarin among patients w/ end-stage renal disease on hemodialysis. Read more: https://bit.ly/2qkM9eV #AHA19 #stroke
In high-risk PCI patients, Impella® was associated with more complications and costs than intra-aortic balloon pumps. http://spr.ly/601113AzS #AHA19 @UCSF #cardiotwitter
Fatigue is the most common symptom experienced by people with cancer. • Almost every cancer patient reports it • Fatigue is often not relieved by rest • Reduced energy & increased need for rest is unrelated to the amount of sleep or activity https://buff.ly/2JECAyX
#OCTCOMPLETE: In this #COMPLETE trial substudy, almost half of STEMI patients with multi-vessel disease were found to have obstructive non-culprit lesions with complex plaque morphology. http://spr.ly/601613A1I #AHA19 @McMasterU #cardiotwitter
